HADH
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial
Also known as: HADH1, HADHSC, HCDH_HUMAN, SCHAD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16836
- Gene
- HADH
- Ensembl
- ENSG00000138796
- Chromosome
- 4
- Canonical length
- 314 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene of this gene on chromosome 15. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
314 residues, UniProt reviewed canonical sequence.
>Q16836|HADH
1 MAFVTRQFMR SVSSSSTASA SAKKIIVKHV TVIGGGLMGA GIAQVAAATG HTVVLVDQTE
61 DILAKSKKGI EESLRKVAKK KFAENLKAGD EFVEKTLSTI ATSTDAASVV HSTDLVVEAI
121 VENLKVKNEL FKRLDKFAAE HTIFASNTSS LQITSIANAT TRQDRFAGLH FFNPVPVMKL
181 VEVIKTPMTS QKTFESLVDF SKALGKHPVS CKDTPGFIVN RLLVPYLMEA IRLYERGDAS
241 KEDIDTAMKL GAGYPMGPFE LLDYVGLDTT KFIVDGWHEM DAENPLHQPS PSLNKLVAEN
301 KFGKKTGEGF YKYKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HADH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 262 nTPM
Expression across tissuesHPA
Tissue
- tongue: 262 nTPM
- skeletal muscle: 234 nTPM
- liver: 211 nTPM
- kidney: 180 nTPM
- heart muscle: 166 nTPM
- adipose tissue: 134 nTPM
Single-cell type
- enterocytes: 338 nCPM
- hepatocytes: 315 nCPM
- parietal cells: 251 nCPM
- enteric transient amplifying cells: 237 nCPM
- early spermatids: 226 nCPM
- hofbauer cells: 201 nCPM
Immune cell
- plasmacytoid DC: 42 nTPM
- myeloid DC: 37 nTPM
- NK-cell: 37 nTPM
- memory B-cell: 32 nTPM
- naive B-cell: 28 nTPM
- naive CD4 T-cell: 23 nTPM
Brain region
- choroid plexus: 35 nTPM
- hypothalamus: 24 nTPM
- white matter: 24 nTPM
- midbrain: 21 nTPM
- spinal cord: 21 nTPM
- medulla oblongata: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HADH.
Disease | AllUniProt
Conditions HADH is implicated in, by any mechanism.
- 3-alpha-hydroxyacyl-CoA dehydrogenase deficiency (HADH deficiency) MIM:231530
- Hyperinsulinemic hypoglycemia, familial, 4 (HHF4) MIM:609975
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 390 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Deficiency of 3-hydroxyacyl-CoA dehydrogenase
- Hyperinsulinemic hypoglycemia, familial, 4
- Hyperinsulinemic hypoglycemia
- Familial hyperinsulinism
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- fatty acid beta-oxidation
- negative regulation of insulin secretion
- positive regulation of cold-induced thermogenesis
- regulation of insulin secretion
- response to activity
- response to insulin
- response to xenobiotic stimulus
- spermatogenesis
Molecular functions
- (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
- identical protein binding
- NAD+ binding
- transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 3-hydroxyacyl-CoA dehydrogenase, C-terminal
- 3-hydroxyacyl-CoA dehydrogenase, NAD binding
- 3-hydroxyacyl-CoA dehydrogenase, conserved site
- 6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
- 6-phosphogluconate dehydrogenase, domain 2
- 3-hydroxyacyl-CoA dehydrogenase
- NAD(P)-binding domain superfamily
- 3-hydroxyacyl-CoA dehydrogenase, C-terminal domain
- 3-hydroxyacyl-CoA dehydrogenase, NAD binding domain
- Mitochondrial 3-hydroxyacyl-CoA dehydrogenase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HADH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HADH as an antibody target. Whether an autoantibody or antibody against HADH could matter depends on whether native HADH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HADH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HADH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...